Archive

Category Archives for "Advocacy"
2

FDA says, “Not Yet”

The Tobacco Products Scientific Advisory Committee recently wrapped up a two-day panel concerning two separate FDA applications submitted by Philip Morris in regard to its IQOS device. The first submittal was a request to sell the IQOS in the U.S. and the second application was in hopes of being able to market the “heat-not-burn” device […]

Continue reading
1

iQOS: “I Quit Ordinary Smoking”

Today (January 24th 2018) and tomorrow (January 25th 2018) are big days for the tobacco industry as the Tobacco Products Scientific Advisory Committee, an advisory panel of the United States Food and Drug Administration, will hold a two-day session on whether or not to consider the Marlboro-branded product called, IQOS, to be sold in the […]

Continue reading
2

Could Vaping be a Long-Term Smoking Cessation Tool?

According to a brand-new study set for publication next month in the Regulatory Toxicology and Pharmacology Journal— vaping has a legitimate case for being used as a long-term smoking cessation tool. Apart from the unhealthy act of smoking, 209 “healthy” smokers took part in the study that set out to better understand the effects of […]

Continue reading

Cancer Deaths Fall: Is Vaping Owed a Debt of Gratitude?

Historical patent records indicate that the first ‘e-cigarette’ appeared in or around the 1920s. At the time, little was known about e-cigarettes, in particular, their potential effects on health. But nevertheless, word got around about this new alternative nicotine intake device and by the late 90s, several major tobacco companies demonstrated a desire to create […]

Continue reading
1

Making The Switch: 5 Celebrities Who Did it

It’s no secret that many former smokers have been able to quit their habit, and remain cigarette-free by switching the way they ingest their nicotine: e-cigarettes. This includes many celebrities and even congressmen. A lot of celebrities attempt to use their overly publicized platform to spread an agenda – maybe even multiple agendas – whether […]

Continue reading
1 3 4 5 6 7 15
>